P
Last Price
52 Week Range
CA$0.02 - CA$0.06
Next Earnings Date
-
Next Earnings Date
-
Last Price
Market Cap | CA$14.95M |
EV | CA$19.50M |
Shares Outstanding | 598.05M |
Beta | 0.17 |
Industry | Biotechnology |
Analyst Rating | - |
Analyst Target Price | - |
Number of Analysts | 0 |
P/E 2020E | - |
P/Revenue 2020E | - |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Revenue | |
EPS | |
Operating Cash Flow | |
Free Cash Flow |
Gross Margin 2020E | - |
Net Profit Margin 2020E | - |
ROE 2020E | - |
ROCE 2019 | - |
DPS 2020E | - |
Payout Ratio 2020E | - |
Div. Yield 2020E | - |
DPS Last 3Y CAGR |
Price
%
1M
3M
6M
1Y
3Y
5Y
P
PreveCeutical Medical Inc.
PREV
Sector
Healthcare
Industry
Biotechnology
CEO
Van Deventer, Stephen
Employees
Website
www.preveceutical.comIPO Date
2017-01-11
Headquarters
5428 Marine Drive, West Vancouver, British Columbia, V7W 2R2, Canada
The last closing price of PreveCeutical Medical (PREV) is CA$0.03, reflecting a +25.00% change from the prior session. Last updated: December 31, 2025 at 4:03 PM Eastern Time
Review the recent PREV stock performance trends:Past 1 Month: PreveCeutical Medical (PREV) shares have +0.00%.Past 3 Months: The stock has -16.67%.Past 6 Months: PREV shares have -16.67%. Last updated: December 31, 2025 at 11:41 PM Eastern Time
Over the last year, PreveCeutical Medical (PREV) has established a 52-week price range between a high of CA$0.06 and a low of CA$0.02. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:41 PM Eastern Time
PreveCeutical Medical (PREV) is considered a low volatility stock. It has a beta of 0.17, which means it typically moves 0.17 times as much as the broader market. Over the past 52 weeks, PREV has traded within a CA$0.02 – CA$0.06 range. Last updated: December 31, 2025 at 11:41 PM Eastern Time
A CA$1,000 investment in PreveCeutical Medical 5 years ago, when the stock was trading around CA$0.04, would be worth approximately CA$833.37 today, based solely on share price performance (excluding dividends). This represents a total return of -16.66% over the period, equivalent to a compound annual growth rate (CAGR) of -3.58%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:41 PM Eastern Time
The current PreveCeutical Medical (PREV) market capitalization is approximately CA$14.95M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, PreveCeutical Medical's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:41 PM Eastern Time
In the most recently reported fiscal year, PreveCeutical Medical (PREV) generated net income of CA$-3.58M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions.
PreveCeutical Medical (PREV) does not currently pay a dividend. Over the last twelve months (LTM), the company paid CA$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.
Based on the latest available analyst coverage, PreveCeutical Medical (PREV) currently carries a not available consensus rating. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: December 31, 2025 at 4:03 PM Eastern Time
Like other publicly traded stocks, PreveCeutical Medical (PREV) shares are bought and sold on stock exchanges such as CNSX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for PreveCeutical Medical (PREV) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.
At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add PREV to your watchlist.
PreveCeutical Medical trades under the ticker symbol PREV on the CNSX stock exchange. The ticker PREV is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.
PreveCeutical Medical (PREV) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest PreveCeutical Medical (PREV) stock peers based on overlapping products, services, and competitive dynamics:Cybin (CYBN)Revive Therapeutics (RVV)Aequus Pharmaceuticals (AQS)Cronos Group (CRON)XORTX Therapeutics (XRTX)Voyageur Pharmaceuticals (VM)Algernon Health (AGN)Appili Therapeutics (APLI)Delivra Health Brands (DHB) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to PreveCeutical Medical.
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.